| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 60,000 | 01 Sep 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics, Inc. | 01 Sep 2022 | 1 | $0 | 4 | Chief Medical Officer | 06 Sep 2022, 20:42 |
| FDMT | 4D Molecular Therapeutics Inc. | 01 Feb 2022 | 1 | $0 | 4 | Chief Medical Officer | 03 Feb 2022, 16:39 |